UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000027159
Receipt number R000031125
Scientific Title Effect of chicken extract on breast milk production of primiparous mothers in Japan: A randomized experimental study
Date of disclosure of the study information 2017/04/28
Last modified on 2018/01/07 12:33:12

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effect of chicken extract on breast milk production of primiparous mothers in Japan: A randomized experimental study

Acronym

Effect of chicken extract on breast milk production

Scientific Title

Effect of chicken extract on breast milk production of primiparous mothers in Japan: A randomized experimental study

Scientific Title:Acronym

Effect of chicken extract on breast milk production

Region

Japan


Condition

Condition

primiparous lactating mothers

Classification by specialty

Nursing

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To assess the effects of chicken extract on breast milk production

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

milk production amount of postpartum 2 days and 4 days

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

No treatment

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Food

Interventions/Control_1

Chicken extract
Since 36 gestation of pregnancy, take 70 ml of Brand of Chicken Essence, twice a day, more than two weeks

Interventions/Control_2

Water
Since 36 gestation of pregnancy, take 70 ml of water, twice a day, more than two weeks

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

36 years-old >

Gender

Female

Key inclusion criteria

Primiparous women who wanted to breastfeed, were healthy, and whose pregnancies proceeded normally.

Key exclusion criteria

A) Exclusion criteria before commencement of test
1) participants have chicken allergy, 2) participants have morphological abnormalities of nipple, 3) participants have scheduled for caesarean section, 4) participants have hypertension, 5)participants have
diabetes, 6) participants have mental illness,
7) anemia (person with Hb of less than 9.0 mg / dl), 8) medicating medicine, 9) judged by physicians to be inappropriate for participation

B) Cancellation criteria after commencement of test
1) person who has become childbirth before 38 weeks gestation, 2) cases where they wish to stop the examination, 3) special mother's or child's abnormality is recognized after starting the exam, 4) cesarean section during the examination who underwent surgery such as surgery, 5) participants who diagnosed by doctors that unsuitable for continued testing

Target sample size

80


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Masayo Awano

Organization

Kanazawa University

Division name

Department of Health Development Nursing, Kanazawa University Graduate School of Medical Science

Zip code


Address

5-11-80 Kodatsuno, Kanazawa, Ishikawa 920-0942, Japan

TEL

076-265-2500

Email

masayo@po2.nsknet.or.jp


Public contact

Name of contact person

1st name
Middle name
Last name Masayo Awano

Organization

Kanazawa University

Division name

Department of Health Development Nursing, Kanazawa University Graduate School of Medical Science

Zip code


Address

81-1-401 Urokomachi Kanazawa Ishikawa

TEL

076-224-4192

Homepage URL


Email

masayo@po2.nsknet.or.jp


Sponsor or person

Institute

NPO Science Research Center Alternative Medicine

Institute

Department

Personal name



Funding Source

Organization

NPO Science Research Center Alternative Medicine

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2017 Year 04 Month 28 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2010 Year 12 Month 01 Day

Date of IRB


Anticipated trial start date

2011 Year 05 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2017 Year 04 Month 27 Day

Last modified on

2018 Year 01 Month 07 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000031125


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name